AUPH Q1 2018 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30,000-3.2% YoY

Gross Profit

-$9M-29523.3% margin

Operating Income

-$13M-43490.0% margin

Net Income

-$15M-51593.3% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

-3.2%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$176M

Total Liabilities

$24M

Stockholders' Equity

$152M

Cash & Equivalents

$131M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30,000	$31,000	-3.2%
Gross Profit	-$9M	$30,000	-29623.3%
Operating Income	-$13M	-$11M	-17.7%
Net Income	-$15M	-$52M	+70.2%